It is estimated that 11,000 new cases of GBM are diagnosed every year and the five-year survival rate is between 5 and 10%.
Researchers from the Abramson Cancer Center of the University of Pennsylvania have found that liquid biopsy can help to predict the prognosis of glioblastoma(GBM), the most aggressive and common brain cancer in adults.












